NATURE . COM {}

Matching Content Categories {📚}

• Education
• Science
• Insurance

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 42,799,894 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

Direct Advertisers (10)

Reseller Advertisers (38)

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$539,300 per month
Our calculations suggest that Nature.com earns between $359,561 and $988,793 monthly online from display advertisements.

Keywords {🔍}

retinal, ischemic, kus, injury, control, cell, layer, article, group, cells, rats, thickness, retina, pubmed, google, scholar, vcp, insult, fig, doi, rgcs, ganglion, ischemia, days, death, effects, outer, neuroprotective, images, nuclear, cas, rat, kustreated, research, stress, model, nature, significantly, bwave, protein, number, diseases, treatment, test, treated, groups, sections, rgc, chop, error,

Topics {✒️}

nature portfolio privacy policy nature genetics 36 nature advertising social media monosodium iodoacetate-induced osteoarthritis pressure-induced ischaemia-reperfusion insult index 0/ reprints author information authors cell death-inducing insults pct/jp2011/067320&pct/jp2011/073160 japan research foundation er stress-induced molecule author correspondence facial nerve research er stress-reducing activities integrated medical bio-imaging nampt-dependent nad+ salvage transgenic thy1-gfp rat proteasome-mediated protein degradation joint research project flat-mounted retinal imaging light-emitting diode stimulator ganglion cell complex fewer tunel-positive cells thy1-green fluorescent protein decreased b-wave amplitude investigator-initiated clinical trial fewer chop-positive rgcs ivt-kus121–treated group compared flat-mounted retinal images ischemia-reperfusion injured retina flat-mounted retinas treated ganglion cell layer profound anti-apoptotic effect retinal ischemia-reperfusion injury permissions 5 mg/kg body weight colorimetric-tdt enzyme assessed b-wave amplitudes vcp/p97 aaa-atpase neuronal cell death human subjects subjected anti-cleaved caspase-3 antibody induces cell death necrotic cell death gfp-positive rgc numbers japan national society

Schema {🗺️}

WebPage:
      mainEntity:
         headline:KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress
         description:Ischemic neural damages cause several devastating diseases, including brain stroke and ischemic retinopathies, and endoplasmic reticulum (ER) stress has been proposed to be the underlying mechanism of the neuronal cell death of these conditions. We previously synthesized Kyoto University substances (KUSs) as modulators of valosin-containing protein (VCP); KUSs inhibit VCP ATPase activity and protect cells from different cell death-inducing insults. Here, we examined the efficacy of KUS121 in a rat model of retinal ischemic injury. Systemic administration of KUS121 to rats with ischemic retinal injury significantly suppressed inner retinal thinning and death of retinal ganglion and amacrine cells, with a significant functional maintenance of visual functions, as judged by electroretinography. Furthermore, intravitreal injection of KUS121, which is the clinically preferred route of drug administration for retinal diseases, appeared to show an equal or better neuroprotective efficacy in the ischemic retina compared with systemic administration. Indeed, induction of the ER stress marker C/EBP homologous protein (CHOP) after the ischemic insult was significantly suppressed by KUS121 administration. Our study suggests VCP modulation by KUS as a promising novel therapeutic strategy for ischemic neuronal diseases.
         datePublished:2017-03-20T00:00:00Z
         dateModified:2017-03-20T00:00:00Z
         pageStart:1
         pageEnd:10
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/srep44873
         keywords:
            Drug discovery
            Neurological disorders
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig5_HTML.jpg
         isPartOf:
            name:Scientific Reports
            issn:
               2045-2322
            volumeNumber:7
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Masayuki Hata
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                     address:
                        name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hanako O. Ikeda
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                     address:
                        name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Chinami Kikkawa
               affiliation:
                     name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd
                     address:
                        name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sachiko Iwai
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                     address:
                        name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuki Muraoka
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tomoko Hasegawa
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Akira Kakizuka
               affiliation:
                     name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology
                     address:
                        name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nagahisa Yoshimura
               affiliation:
                     name:Kyoto University Graduate School of Medicine
                     address:
                        name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                     address:
                        name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress
      description:Ischemic neural damages cause several devastating diseases, including brain stroke and ischemic retinopathies, and endoplasmic reticulum (ER) stress has been proposed to be the underlying mechanism of the neuronal cell death of these conditions. We previously synthesized Kyoto University substances (KUSs) as modulators of valosin-containing protein (VCP); KUSs inhibit VCP ATPase activity and protect cells from different cell death-inducing insults. Here, we examined the efficacy of KUS121 in a rat model of retinal ischemic injury. Systemic administration of KUS121 to rats with ischemic retinal injury significantly suppressed inner retinal thinning and death of retinal ganglion and amacrine cells, with a significant functional maintenance of visual functions, as judged by electroretinography. Furthermore, intravitreal injection of KUS121, which is the clinically preferred route of drug administration for retinal diseases, appeared to show an equal or better neuroprotective efficacy in the ischemic retina compared with systemic administration. Indeed, induction of the ER stress marker C/EBP homologous protein (CHOP) after the ischemic insult was significantly suppressed by KUS121 administration. Our study suggests VCP modulation by KUS as a promising novel therapeutic strategy for ischemic neuronal diseases.
      datePublished:2017-03-20T00:00:00Z
      dateModified:2017-03-20T00:00:00Z
      pageStart:1
      pageEnd:10
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/srep44873
      keywords:
         Drug discovery
         Neurological disorders
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_Article_BFsrep44873_Fig5_HTML.jpg
      isPartOf:
         name:Scientific Reports
         issn:
            2045-2322
         volumeNumber:7
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Masayuki Hata
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
                  name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                  address:
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hanako O. Ikeda
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
                  name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                  address:
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Chinami Kikkawa
            affiliation:
                  name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd
                  address:
                     name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sachiko Iwai
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
                  name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                  address:
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuki Muraoka
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tomoko Hasegawa
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Akira Kakizuka
            affiliation:
                  name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology
                  address:
                     name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nagahisa Yoshimura
            affiliation:
                  name:Kyoto University Graduate School of Medicine
                  address:
                     name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
                  name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
                  address:
                     name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Scientific Reports
      issn:
         2045-2322
      volumeNumber:7
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
      address:
         name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
         type:PostalAddress
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
      address:
         name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
         type:PostalAddress
      name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd
      address:
         name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan
         type:PostalAddress
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
      address:
         name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
         type:PostalAddress
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology
      address:
         name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto, Japan
         type:PostalAddress
      name:Kyoto University Graduate School of Medicine
      address:
         name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
         type:PostalAddress
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
      address:
         name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Masayuki Hata
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
            name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
            address:
               name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Hanako O. Ikeda
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
            name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
            address:
               name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Chinami Kikkawa
      affiliation:
            name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd
            address:
               name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan
               type:PostalAddress
            type:Organization
      name:Sachiko Iwai
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
            name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
            address:
               name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Yuki Muraoka
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Tomoko Hasegawa
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Akira Kakizuka
      affiliation:
            name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology
            address:
               name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Nagahisa Yoshimura
      affiliation:
            name:Kyoto University Graduate School of Medicine
            address:
               name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
               type:PostalAddress
            type:Organization
            name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital
            address:
               name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
      name:Pharmacology Group, Non-clinical Research, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Laboratory of Functional Biology, Kyoto University Graduate School of Biostudies & Solution Oriented Research for Science and Technology, Kyoto, Japan
      name:Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
      name:Neuroprotective Treatment Project for Ocular Diseases, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan

Social Networks {👍}(2)

• https://www.facebook.com/scientificreports
• https://twitter.com/SciReports

External Links {🔗}(120)

• How much profit does https://doi.org/10.1161%2FCIR.0b013e31823ac046 generate?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22179539 make?
• How much does http://scholar.google.com/scholar_lookup?&title=Heart%20disease%20and%20stroke%20statistics%E2%80%932012%20update%3A%20a%20report%20from%20the%20American%20Heart%20Association&journal=Circulation&doi=10.1161%2FCIR.0b013e31823ac046&volume=125&pages=e2-e220&publication_year=2012&author=Roger%2CVL net monthly?
• How much does https://doi.org/10.1016%2Fj.jemermed.2012.05.005 bring in each month?
• What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22818644?
• http://scholar.google.com/scholar_lookup?&title=Tissue%20plasminogen%20activator%20and%20stroke%3A%20review%20of%20the%20literature%20for%20the%20clinician&journal=J%20Emerg%20Med&doi=10.1016%2Fj.jemermed.2012.05.005&volume=43&pages=1149-1154&publication_year=2012&author=DeMers%2CG&author=Meurer%2CWJ&author=Shih%2CR&author=Rosenbaum%2CS&author=Vilke%2CGM income
• How much cash flow does https://doi.org/10.1016%2Fj.preteyeres.2003.12.001 have monthly?
• Revenue of http://scholar.google.com/scholar_lookup?&title=Retinal%20ischemia%3A%20mechanisms%20of%20damage%20and%20potential%20therapeutic%20strategies&journal=Prog%20Retin%20Eye%20Res&doi=10.1016%2Fj.preteyeres.2003.12.001&volume=23&pages=91-147&publication_year=2004&author=Osborne%2CNN
• How much does https://doi.org/10.1167%2Fiovs.06-0510 pull in?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17197555 rake in every month?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Retinal%20ischemia%20and%20reperfusion%20causes%20capillary%20degeneration%3A%20similarities%20to%20diabetes&journal=Invest%20Ophthalmol%20Vis%20Sci&doi=10.1167%2Fiovs.06-0510&volume=48&pages=361-367&publication_year=2007&author=Zheng%2CL&author=Gong%2CB&author=Hatala%2CDA&author=Kern%2CTS is on a monthly basis
• How much revenue does https://link.springer.com/doi/10.1007/BF00155046 bring in?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=817878 bring in each month?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Tributary%20vein%20obstruction%3A%20pathogenesis%20and%20treatment%20of%20sequelae&journal=Doc%20Ophthalmol&doi=10.1007%2FBF00155046&volume=40&pages=339-360&publication_year=1976&author=Archer%2CDB?
• Get to know what's the income of https://doi.org/10.1038%2Fsj.cdd.4401365
• Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14752508
• Income figures for http://scholar.google.com/scholar_lookup?&title=Ischemia-induced%20neuronal%20cell%20death%20is%20mediated%20by%20the%20endoplasmic%20reticulum%20stress%20pathway%20involving%20CHOP&journal=Cell%20Death%20Differ&doi=10.1038%2Fsj.cdd.4401365&volume=11&pages=403-415&publication_year=2004&author=Tajiri%2CS
• Get to know https://doi.org/10.1016%2Fj.neulet.2014.05.042's earnings
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24880098 make?
• How much does http://scholar.google.com/scholar_lookup?&title=Down-regulation%20of%20GRP78%20enhances%20apoptosis%20via%20CHOP%20pathway%20in%20retinal%20ischemia-reperfusion%20injury&journal=Neurosci%20Lett&doi=10.1016%2Fj.neulet.2014.05.042&volume=575&pages=68-73&publication_year=2014&author=Li%2CH&author=Zhu%2CX&author=Fang%2CF&author=Jiang%2CD&author=Tang%2CL gross monthly?
• Find out how much https://doi.org/10.1016%2Fj.brainres.2009.10.025 earns monthly
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19853589's gross income?
• http://scholar.google.com/scholar_lookup?&title=Retinal%20ganglion%20cell%20death%20induced%20by%20endoplasmic%20reticulum%20stress%20in%20a%20chronic%20glaucoma%20model&journal=Brain%20Res&doi=10.1016%2Fj.brainres.2009.10.025&volume=1308&pages=158-166&publication_year=2010&author=Doh%2CSH&author=Kim%2CJH&author=Lee%2CKM&author=Park%2CHY&author=Park%2CCK's revenue stream
• Discover the revenue of https://doi.org/10.2147%2FOPTH.S3009
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19668425
• What's the financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699777?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Increased%20expression%20of%20IRE1alpha%20and%20stress-related%20signal%20transduction%20proteins%20in%20ischemia-reperfusion%20injured%20retina&journal=Clin%20Ophthalmol&doi=10.2147%2FOPTH.S3009&volume=2&pages=743-752&publication_year=2008&author=Hata%2CN&author=Oshitari%2CT&author=Yokoyama%2CA&author=Mitamura%2CY&author=Yamamoto%2CS is on a monthly basis
• Financial intake of https://doi.org/10.1038%2Fsj.cdd.4400955
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11859409
• How much profit does http://scholar.google.com/scholar_lookup?&title=Identification%20of%20ter94%2C%20Drosophila%20VCP%2C%20as%20a%20modulator%20of%20polyglutamine-induced%20neurodegeneration&journal=Cell%20Death%20Differ&doi=10.1038%2Fsj.cdd.4400955&volume=9&pages=264-273&publication_year=2002&author=Higashiyama%2CH generate?
• How much cash flow does https://doi.org/10.1038%2Fng1332 have monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15034582 rake in every month?
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Inclusion%20body%20myopathy%20associated%20with%20Paget%20disease%20of%20bone%20and%20frontotemporal%20dementia%20is%20caused%20by%20mutant%20valosin-containing%20protein&journal=Nature%20genetics&doi=10.1038%2Fng1332&volume=36&pages=377-381&publication_year=2004&author=Watts%2CGD each month?
• How much revenue does https://doi.org/10.1016%2Fj.neuron.2010.11.036 produce monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21145000 gross monthly?
• How profitable is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032425?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Exome%20sequencing%20reveals%20VCP%20mutations%20as%20a%20cause%20of%20familial%20ALS&journal=Neuron&doi=10.1016%2Fj.neuron.2010.11.036&volume=68&pages=857-864&publication_year=2010&author=Johnson%2CJO
• Check the income stats for https://doi.org/10.1016%2Fj.tibs.2011.06.001
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21741246's gross income?
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Cdc48%3A%20a%20power%20machine%20in%20protein%20degradation&journal=Trends%20Biochem%20Sci&doi=10.1016%2Fj.tibs.2011.06.001&volume=36&pages=515-523&publication_year=2011&author=Stolz%2CA&author=Hilt%2CW&author=Buchberger%2CA&author=Wolf%2CDH each month?
• How much money does https://doi.org/10.1038%2Fncb2407 make?
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22298039 earning monthly?
• How much profit is http://scholar.google.com/scholar_lookup?&title=Emerging%20functions%20of%20the%20VCP%2Fp97%20AAA-ATPase%20in%20the%20ubiquitin%20system&journal=Nat%20Cell%20Biol&doi=10.1038%2Fncb2407&volume=14&pages=117-123&publication_year=2012&author=Meyer%2CH&author=Bug%2CM&author=Bremer%2CS making per month?
• What's the financial gain of https://doi.org/10.1016%2Fj.bbamcr.2011.09.002?
• How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21945179 have monthly?
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=The%20Cdc48%20machine%20in%20endoplasmic%20reticulum%20associated%20protein%20degradation&journal=Biochim%20Biophys%20Acta&doi=10.1016%2Fj.bbamcr.2011.09.002&volume=1823&pages=117-124&publication_year=2012&author=Wolf%2CDH&author=Stolz%2CA?
• Earnings of https://doi.org/10.1038%2Fsrep05970
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25096051 gross monthly?
• How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122966 produce monthly?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Novel%20VCP%20modulators%20mitigate%20major%20pathologies%20of%20rd10%2C%20a%20mouse%20model%20of%20retinitis%20pigmentosa&journal=Sci%20Rep&doi=10.1038%2Fsrep05970&volume=4&publication_year=2014&author=Ikeda%2CHO?
• Profit of https://doi.org/10.1038%2Fsrep31184
• Learn how profitable http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2016NatSR...631184H is on a monthly basis
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27503804
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977562 rake in every month?
• How much does http://scholar.google.com/scholar_lookup?&title=Neuroprotective%20efficacies%20by%20KUS121%2C%20a%20VCP%20modulator%2C%20on%20animal%20models%20of%20retinal%20degeneration&journal=Sci%20Rep&doi=10.1038%2Fsrep31184&volume=6&publication_year=2016&author=Hasegawa%2CT bring in each month?
• Monthly income for https://doi.org/10.1001%2Farchfacial.2010.71
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20855773?
• How much money does http://scholar.google.com/scholar_lookup?&title=A%20new%20model%20for%20facial%20nerve%20research%3A%20the%20novel%20transgenic%20Thy1-GFP%20rat&journal=Arch%20Facial%20Plast%20Surg&doi=10.1001%2Farchfacial.2010.71&volume=12&pages=315-320&publication_year=2010&author=Magill%2CCK&author=Moore%2CAM&author=Borschel%2CGH&author=Mackinnon%2CSE generate?
• What are the earnings of https://doi.org/10.1016%2FS0014-4835%2805%2980173-3?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1483506's total income per month
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Cell%20death%20in%20the%20rat%20retina%20after%20a%20pressure-induced%20ischaemia-reperfusion%20insult%3A%20an%20electron%20microscopic%20study.%20I.%20Ganglion%20cell%20layer%20and%20inner%20nuclear%20layer&journal=Exp%20Eye%20Res&doi=10.1016%2FS0014-4835%2805%2980173-3&volume=55&pages=605-613&publication_year=1992&author=Buchi%2CER?
• How much does https://doi.org/10.1167%2Fiovs.07-1211 bring in each month?
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18689704
• Income figures for http://scholar.google.com/scholar_lookup?&title=Imaging%20mouse%20retinal%20ganglion%20cells%20and%20their%20loss%20in%20vivo%20by%20a%20fundus%20camera%20in%20the%20normal%20and%20ischemia-reperfusion%20model&journal=Invest%20Ophthalmol%20Vis%20Sci&doi=10.1167%2Fiovs.07-1211&volume=49&pages=5546-5552&publication_year=2008&author=Murata%2CH
• Income figures for https://doi.org/10.1167%2Fiovs.13-13372
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Loss%20of%20inner%20retinal%20neurons%20after%20retinal%20ischemia%20in%20rats&journal=Invest%20Ophthalmol%20Vis%20Sci&doi=10.1167%2Fiovs.13-13372&volume=55&pages=2777-2787&publication_year=2014&author=Schmid%2CH&author=Renner%2CM&author=Dick%2CHB&author=Joachim%2CSC
• Earnings of https://doi.org/10.1016%2Fj.preteyeres.2007.09.003
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18042420 bring in?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Rodent%20electroretinography%3A%20methods%20for%20extraction%20and%20interpretation%20of%20rod%20and%20cone%20responses&journal=Prog%20Retin%20Eye%20Res&doi=10.1016%2Fj.preteyeres.2007.09.003&volume=27&pages=1-44&publication_year=2008&author=Weymouth%2CAE&author=Vingrys%2CAJ generate?
• What's the income of https://doi.org/10.1016%2F0014-4835%2891%2990215-Z?
• http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=1991elpa.book.....H income
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1743256?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Quantitation%20of%20ischemic%20damage%20in%20the%20rat%20retina&journal=Exp%20Eye%20Res&doi=10.1016%2F0014-4835%2891%2990215-Z&volume=53&pages=573-582&publication_year=1991&author=Hughes%2CWF produce monthly?
• What's the financial gain of https://doi.org/10.1167%2Fiovs.09-4086?
• How much income is http://scholar.google.com/scholar_lookup?&title=Retinal%20protection%20from%20acute%20glaucoma-induced%20ischemia-reperfusion%20injury%20through%20pharmacologic%20induction%20of%20heme%20oxygenase-1&journal=Invest%20Ophthalmol%20Vis%20Sci&doi=10.1167%2Fiovs.09-4086&volume=51&pages=4798-4808&publication_year=2010&author=Sun%2CMH earning monthly?
• What's the revenue for https://doi.org/10.1016%2FS0306-3623%2897%2900359-5?
• What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9510075 each month?
• Profit of http://scholar.google.com/scholar_lookup?&title=The%20b-wave%20of%20the%20electroretinogram%20as%20an%20index%20of%20retinal%20ischemia&journal=Gen%20Pharmacol&doi=10.1016%2FS0306-3623%2897%2900359-5&volume=30&pages=281-287&publication_year=1998&author=Block%2CF&author=Schwarz%2CM
• https://doi.org/10.1056%2FNEJMe1103334's revenue stream
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21526924
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Bevacizumab%20versus%20ranibizumab%20for%20AMD&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMe1103334&volume=364&pages=1966-1967&publication_year=2011&author=Rosenfeld%2CPJ generate?
• Get to know what's the income of https://doi.org/10.1056%2FNEJMoa1414264
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25692915
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Aflibercept%2C%20bevacizumab%2C%20or%20ranibizumab%20for%20diabetic%20macular%20edema&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1414264&volume=372&pages=1193-1203&publication_year=2015&author=Wells%2CJA generate?
• Earnings of https://doi.org/10.1016%2FS0161-6420%2891%2932135-3
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20tolerance%20of%20intravitreal%20ganciclovir%20in%20cytomegalovirus%20retinitis%20in%20acquired%20immune%20deficiency%20syndrome&journal=Ophthalmology&doi=10.1016%2FS0161-6420%2891%2932135-3&volume=98&pages=1353-1345&publication_year=1991&author=Cochereau-Massin%2CI
• Explore the financials of https://doi.org/10.1111%2Fj.1755-3768.2011.02247.x
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21914149
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Repeat%20intravitreal%20triamcinolone%20acetonide%20injections%20in%20uveitic%20macular%20oedema&journal=Acta%20Ophthalmol&doi=10.1111%2Fj.1755-3768.2011.02247.x&volume=90&pages=e323-325&publication_year=2012&author=Sallam%2CA
• What's the income generated by https://citation-needed.springer.com/v2/references/10.1038/srep44873?format=refman&flavour=references each month?
• Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Masayuki%20Hata
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Masayuki%20Hata%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
• How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hanako%20O.%20Ikeda earning monthly?
• Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hanako%20O.%20Ikeda%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chinami%20Kikkawa gross monthly?
• How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chinami%20Kikkawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sachiko%20Iwai gross monthly?
• What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sachiko%20Iwai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuki%20Muraoka?
• What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuki%20Muraoka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tomoko%20Hasegawa
• What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tomoko%20Hasegawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Akira%20Kakizuka
• What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Akira%20Kakizuka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Nagahisa%20Yoshimura make?
• How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Nagahisa%20Yoshimura%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
• Earnings of https://static-content.springer.com/esm/art%3A10.1038%2Fsrep44873/MediaObjects/41598_2017_BFsrep44873_MOESM49_ESM.pdf
• How much does http://creativecommons.org/licenses/by/4.0/ pull in?
• Find out how much https://s100.copyright.com/AppDispatchServlet?title=KUS121%2C%20a%20VCP%20modulator%2C%20attenuates%20ischemic%20retinal%20cell%20death%20via%20suppressing%20endoplasmic%20reticulum%20stress&author=Masayuki%20Hata%20et%20al&contentID=10.1038%2Fsrep44873©right=The%20Author%28s%29&publication=2045-2322&publicationDate=2017-03-20&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY earns monthly
• Explore the financials of https://crossmark.crossref.org/dialog/?doi=10.1038/srep44873
• What's the income generated by https://citation-needed.springer.com/v2/references/10.1038/srep44873?format=refman&flavour=citation each month?
• Financial intake of https://doi.org/10.1038/s41420-022-01007-3
• Financial intake of https://doi.org/10.1038/s41598-022-20497-w
• Check the income stats for https://doi.org/10.1038/s41598-021-95173-6
• What's the income generated by https://doi.org/10.1038/s41598-020-61160-6 each month?
• How much revenue does https://doi.org/10.1038/s41598-020-77735-2 bring in?
• How much income does https://www.protocols.io/ have?
• https://www.natureindex.com/'s total income per month
• What are the total earnings of http://www.naturechina.com?
• What's the revenue for https://www.natureasia.com/ja-jp?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Prism.js
• Zoom.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk

CDN Services {📦}

• Crossref